Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study | The FDA has put a clinical hold on a Tenaya ...
Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
The current negative list restricts foreign investment in the development and application of human stem cells and gene ...
Emirates News Agency on MSN
Global experts unite in Abu Dhabi to shape the future of pediatric bone marrow transplantation and gene therapy
The congress also focuses on the UAE’s growing contributions to regional healthcare advancement, including the development of ...
The company reported a 16% year-over-year increase in Life Sciences revenue, making up 55% of total revenue from continuing operations, with BioStorage - Bioservices revenue up 21%.
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...
TSHA-102 granted Breakthrough Therapy designation by FDAFinalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month ...
The research will support the implementation of precision medicine efforts for the population. Read more at straitstimes.com. Read more at straitstimes.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback